HopeStage
Back to all studies
Not Yet RecruitingNCT07469501

Comparing Outpatient Treatment Retention Among Individuals Using Fentanyl Randomized to Low-dose and Direct-to-inject Buprenorphine Initiation

Medication studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
San FranciscoSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: June 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
50
Sponsor
University of California, San Francisco
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT07469501
Official title
Show the full official title

Improving Buprenorphine Initiation Among Individuals With Opioid Use Disorder Using Fentanyl

Recruitment & locations

Not yet recruiting

San Francisco

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, San Francisco, a university.

Does this study involve medication?

Yes. The study involves medication, including Injectable buprenorphine and Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic tablets).

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies